What Is the Comparative Efficacy of Surgical, Endoscopic, Transanal Resection, and Radiotherapy Modalities in the Treatment of Rectal Cancer?
- PMID: 37628544
- PMCID: PMC10454130
- DOI: 10.3390/healthcare11162347
What Is the Comparative Efficacy of Surgical, Endoscopic, Transanal Resection, and Radiotherapy Modalities in the Treatment of Rectal Cancer?
Abstract
Background: Rectal cancer is a significant healthcare burden, and effective treatment is crucial. This research aims to compare the effectiveness of surgical and endoscopic resection, transanal resection, and radiotherapy.
Methods: A literature analysis was conducted in order to identify relevant studies, by comparing the different surgical approaches and variables affecting treatment decisions. The findings were analyzed and synthesized to provide a comprehensive overview.
Results: Surgical treatment, particularly TME (total mesorectal excision), proved consistent efficacy in achieving complete tumor resection and improving long-term survival. Endoscopic treatment and transanal resection techniques were promising for early-stage tumors but were associated with higher local recurrence rates. Radiotherapy, especially in combination with chemotherapy, played a crucial role in locally advanced cases, improving local control and reducing recurrence risk. Patient data, tumor characteristics, and healthcare system factors were identified as important factors in treatment modality selection.
Conclusion: Surgical treatment, specifically TME, remains the recommended standard approach for rectal cancer, providing excellent oncological outcomes. Endoscopic treatment and transanal resection techniques can be considered for selected early-stage cases, while radiotherapy is beneficial for locally advanced tumors. Treatment decisions should be personalized based on patient and tumor characteristics, considering the available resources and expertise within the healthcare system.
Keywords: TEM; TME; TaTME; radiotherapy.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Long-term outcomes by a transanal approach to total mesorectal excision for rectal cancer.Surg Endosc. 2017 Dec;31(12):5248-5257. doi: 10.1007/s00464-017-5597-7. Epub 2017 Jun 22. Surg Endosc. 2017. PMID: 28643051
-
Beyond transanal total mesorectal excision: short-term outcomes of transanal total mesorectal excision in locally advanced rectal cancer requiring resection beyond total mesorectal excision.Colorectal Dis. 2021 Apr;23(4):823-833. doi: 10.1111/codi.15446. Epub 2020 Dec 19. Colorectal Dis. 2021. PMID: 33217140
-
[Safety and prognosis analysis of transanal total mesorectal excision versus laparoscopic mesorectal excision for mid-low rectal cancer].Zhonghua Wei Chang Wai Ke Za Zhi. 2022 Jun 25;25(6):522-530. doi: 10.3760/cma.j.cn441530-20210811-00321. Zhonghua Wei Chang Wai Ke Za Zhi. 2022. PMID: 35754217 Chinese.
-
Transanal endoscopic microsurgery for rectal cancer: T1 and beyond? An evidence-based review.Surg Endosc. 2016 Nov;30(11):4841-4852. doi: 10.1007/s00464-016-4818-9. Epub 2016 Feb 22. Surg Endosc. 2016. PMID: 26902614 Review.
-
[Transanal total mesorectal excision-a critical appraisal].Chirurg. 2019 Jun;90(6):478-486. doi: 10.1007/s00104-019-0945-x. Chirurg. 2019. PMID: 30911795 Review. German.
Cited by
-
Prognostic Value of Tumor Volume, Tumor Volume Reduction Rate and Magnetic Resonance Tumor Regression Grade in Rectal Cancer.Medicina (Kaunas). 2023 Dec 18;59(12):2194. doi: 10.3390/medicina59122194. Medicina (Kaunas). 2023. PMID: 38138297 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources